Menu Search
Equities

Smiths Group PLC

QS2A:DUS

Smiths Group PLC

Actions
  • Price (EUR)16.65
  • Today's Change-0.135 / -0.80%
  • Shares traded0.00
  • 1 Year change-13.89%
  • Beta0.7670
Data delayed at least 15 minutes, as of May 21 2019 07:06 BST.
More ▼

Profile data is unavailable for this security.

About the company

Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. John Crane provides mission-critical solutions for pumps, compressors, and other rotating equipment across process industries. Smiths Medical offers medical devices and consumables in the select segments of the infusion systems, vascular access and vital care markets. Smiths Detection produces equipment for air transportation, ports and borders, urban security and military end-use markets. Smiths Interconnect provides high-reliability connectivity solutions for the defence, aerospace, space, rail, medical and semiconductor test end markets. Flex-Tek provides engineered components that heat and move fluids and gases for aerospace, consumer products, construction, medical and industrial applications.

  • Revenue in GBP (TTM)3.24bn
  • Net income in GBP301.00m
  • Incorporated1914
  • Employees21.70k
  • Location
    Smiths Group PLC4th Fl, 11-12 St. James's SquareLONDON SW1Y 4LBUnited KingdomGBR
  • Phone+44 20 7004 1600
  • Fax+44 20 7004 1644
  • Websitehttp://www.smiths.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		SMIN:LSE since
announced		Transaction
value
United Flexible IncAnnounced04 Oct 201804 Oct 2018Announced-0.77%345.00m
Data delayed at least 20 minutes, as of May 21 2019 08:01 BST.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.